We have the joy to announce that Dr. Jussi Kosola has started the SVF knee osteoarthritis study in Finland.
Q-graft is he only system for harvesting regenerative cells (SVF) that can be used at the point-of-care.
The new compact Q-graft® system for the intraoperative separation and collection of regenerative cells (stromal vascular fraction/ SVF) from adipose tissue will support and enhance the research and clinical application of SVF cells for many therapeutic indications.
Unlike other methods, the Q-graft® system stays on the sterile instrument table in the OR throughout the treatment and thus at the point-of-care.
Mediq Eesti OÜ
Väljaotsa 2, Saue
The newly Calistar S study published in the International Urogynecology Jou...
Simunec 2020 - Treatment of Grade 3 and 4 Osteoarthritis...
MedStar manufactures disposable protective face shields for hospital use. H...